Latest Carl June Stories
ANN ARBOR, Mich., June 4, 2014 /PRNewswire-USNewswire/ -- A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014
A professor of immunology at the University of Pennsylvania’s Perelman School of Medicine, Dr.
Immunotherapy is one of the most exciting new approaches to treating cancer. Dr.
Non-profit provides tens of millions in grants since founding by Barbara and Edward Netter in 2001 STAMFORD, Conn., Dec.
The Cancer Research Institute (CRI) declares June “Cancer Immunotherapy Awareness Month” to increase awareness of cancer immunotherapy, a new class of cancer treatment that mobilizes the immune
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine.
In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.
RICHMOND, Calif., March 3, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc.
RICHMOND, Calif., Feb. 28, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of positive preliminary clinical data from its Phase 1 trial (SB-728-902).
- A political dynamiter.